Mitochon Pharmaceuticals Inc logo

Mitochon Pharmaceuticals, Inc.

Mitochon Pharmaceuticals is a start-up biotech company, developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs with primarily focused on neurodegenerative & neuromuscular diseases.

Mitochon is supported by Ben Franklin Technology Partners Southeastern PA, an initiative of the Pennsylvania Department of Community and Economic Development funded by the Ben Franklin Technology Development Authority.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.mitochonpharma.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
259 Radnor Chester Road Suite 210, PA 19087
Radnor
United States
Email
Contact Number
+1 215-313-3905

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/mitochon-pharmaceuticals” connections=”true” suffix=””]

In May 2016, Mitochon raised $1.6Mn for the further development of its lead compound MP101, into human studies, as well as, for MP201 IND filing. Investors included Ben Franklin Technology Partners and Private Investors.